EPCAM and Leigh syndrome: The analysis included 2,723 individuals with a molecular genetic diagnosis of LS, carrying pathogenic or likely pathogenic variants in MLH1, MSH2, MSH6, PMS2 or EPCAM (see Table 1A for LS individual demographics).